Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 11Squamous Cell Carcinoma of Head and Neck 7Thyroid Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Neoplasms 2Salivary Gland Malignant Neoplasms 1Recurrence 1Precancerous Conditions 1Mouth Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Head and Neck Squamous Cell Cancer 1Head and Neck Neoplasms 1

Interventions

Cisplatin 2sintilimab 1Sodium Chloride 1Resistance Training 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Nutrition Assessment 1Counseling 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Head and Neck Squamous Cell Carcinoma × sintilimab × Head & Neck × Clear all
NCT06240689 2024-02-05

A Prospective Randomized Controlled Study of Immune Checkpoint Maintenance Therapy After Radiotherapy and Chemotherapy for Locally Advanced Head and Neck Tumors Based on Peripheral Blood CD8Tex Detection in Peripheral Blood

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Recruiting
104 enrolled
Head & Neck

Locally Advanced Head and Neck Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡